CN107406889A - By injecting the selection based on drop carried out - Google Patents
By injecting the selection based on drop carried out Download PDFInfo
- Publication number
- CN107406889A CN107406889A CN201680016459.8A CN201680016459A CN107406889A CN 107406889 A CN107406889 A CN 107406889A CN 201680016459 A CN201680016459 A CN 201680016459A CN 107406889 A CN107406889 A CN 107406889A
- Authority
- CN
- China
- Prior art keywords
- enzyme
- bacillus
- drop
- polynucleotides
- interested
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000790 Enzymes Proteins 0.000 claims abstract description 78
- 102000004190 Enzymes Human genes 0.000 claims abstract description 76
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 76
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 76
- 239000002157 polynucleotide Substances 0.000 claims abstract description 76
- 238000000034 method Methods 0.000 claims abstract description 40
- 239000000839 emulsion Substances 0.000 claims abstract description 21
- 229940088598 enzyme Drugs 0.000 claims description 73
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 20
- 239000000243 solution Substances 0.000 claims description 20
- 239000000758 substrate Substances 0.000 claims description 19
- 239000004382 Amylase Substances 0.000 claims description 14
- 108010065511 Amylases Proteins 0.000 claims description 14
- 102000013142 Amylases Human genes 0.000 claims description 14
- 235000019418 amylase Nutrition 0.000 claims description 14
- 108020004414 DNA Proteins 0.000 claims description 13
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 11
- 239000002773 nucleotide Substances 0.000 claims description 11
- 125000003729 nucleotide group Chemical group 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 10
- 238000012408 PCR amplification Methods 0.000 claims description 10
- 244000063299 Bacillus subtilis Species 0.000 claims description 9
- 230000005684 electric field Effects 0.000 claims description 9
- 241000194108 Bacillus licheniformis Species 0.000 claims description 8
- 238000004581 coalescence Methods 0.000 claims description 8
- -1 glucanotransferase Proteins 0.000 claims description 8
- 108010059892 Cellulase Proteins 0.000 claims description 6
- 108010089934 carbohydrase Proteins 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 6
- 239000007924 injection Substances 0.000 claims description 6
- 241001328122 Bacillus clausii Species 0.000 claims description 5
- 102000004157 Hydrolases Human genes 0.000 claims description 5
- 108090000604 Hydrolases Proteins 0.000 claims description 5
- 108010029541 Laccase Proteins 0.000 claims description 5
- 108010011619 6-Phytase Proteins 0.000 claims description 4
- 108010024976 Asparaginase Proteins 0.000 claims description 4
- 102000015790 Asparaginase Human genes 0.000 claims description 4
- 241000193752 Bacillus circulans Species 0.000 claims description 4
- 241000193749 Bacillus coagulans Species 0.000 claims description 4
- 241000193422 Bacillus lentus Species 0.000 claims description 4
- 241000194107 Bacillus megaterium Species 0.000 claims description 4
- 241000194103 Bacillus pumilus Species 0.000 claims description 4
- 241000193388 Bacillus thuringiensis Species 0.000 claims description 4
- 241000193764 Brevibacillus brevis Species 0.000 claims description 4
- 102000005367 Carboxypeptidases Human genes 0.000 claims description 4
- 108010006303 Carboxypeptidases Proteins 0.000 claims description 4
- 108010031396 Catechol oxidase Proteins 0.000 claims description 4
- 102000030523 Catechol oxidase Human genes 0.000 claims description 4
- 108010022172 Chitinases Proteins 0.000 claims description 4
- 102000012286 Chitinases Human genes 0.000 claims description 4
- 108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 claims description 4
- 108010001682 Dextranase Proteins 0.000 claims description 4
- 108090000371 Esterases Proteins 0.000 claims description 4
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims description 4
- 102100022624 Glucoamylase Human genes 0.000 claims description 4
- 108010043121 Green Fluorescent Proteins Proteins 0.000 claims description 4
- 102000004144 Green Fluorescent Proteins Human genes 0.000 claims description 4
- 102000004195 Isomerases Human genes 0.000 claims description 4
- 108090000769 Isomerases Proteins 0.000 claims description 4
- 102000003960 Ligases Human genes 0.000 claims description 4
- 108090000364 Ligases Proteins 0.000 claims description 4
- 108090001060 Lipase Proteins 0.000 claims description 4
- 102000004882 Lipase Human genes 0.000 claims description 4
- 239000004367 Lipase Substances 0.000 claims description 4
- 102100024295 Maltase-glucoamylase Human genes 0.000 claims description 4
- 108091005804 Peptidases Proteins 0.000 claims description 4
- 102000035195 Peptidases Human genes 0.000 claims description 4
- 102000003992 Peroxidases Human genes 0.000 claims description 4
- 102000004357 Transferases Human genes 0.000 claims description 4
- 108090000992 Transferases Proteins 0.000 claims description 4
- 102000005840 alpha-Galactosidase Human genes 0.000 claims description 4
- 108010030291 alpha-Galactosidase Proteins 0.000 claims description 4
- 108010028144 alpha-Glucosidases Proteins 0.000 claims description 4
- 229960003272 asparaginase Drugs 0.000 claims description 4
- DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 claims description 4
- 229940054340 bacillus coagulans Drugs 0.000 claims description 4
- 229940097012 bacillus thuringiensis Drugs 0.000 claims description 4
- 125000000188 beta-D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 4
- 108010051210 beta-Fructofuranosidase Proteins 0.000 claims description 4
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 4
- 102000005936 beta-Galactosidase Human genes 0.000 claims description 4
- 229940106157 cellulase Drugs 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 4
- 108010005400 cutinase Proteins 0.000 claims description 4
- 238000004925 denaturation Methods 0.000 claims description 4
- 230000036425 denaturation Effects 0.000 claims description 4
- 239000005090 green fluorescent protein Substances 0.000 claims description 4
- 239000001573 invertase Substances 0.000 claims description 4
- 235000011073 invertase Nutrition 0.000 claims description 4
- 235000019421 lipase Nutrition 0.000 claims description 4
- 230000001590 oxidative effect Effects 0.000 claims description 4
- 229920001277 pectin Polymers 0.000 claims description 4
- 239000001814 pectin Substances 0.000 claims description 4
- 235000010987 pectin Nutrition 0.000 claims description 4
- 229940072417 peroxidase Drugs 0.000 claims description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 4
- 229940085127 phytase Drugs 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- 108090000915 Aminopeptidases Proteins 0.000 claims description 3
- 102000004400 Aminopeptidases Human genes 0.000 claims description 3
- 241000193744 Bacillus amyloliquefaciens Species 0.000 claims description 3
- 238000001712 DNA sequencing Methods 0.000 claims description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 3
- 108010053770 Deoxyribonucleases Proteins 0.000 claims description 3
- 102000016911 Deoxyribonucleases Human genes 0.000 claims description 3
- 102000004317 Lyases Human genes 0.000 claims description 3
- 108090000856 Lyases Proteins 0.000 claims description 3
- 108010054377 Mannosidases Proteins 0.000 claims description 3
- 102000001696 Mannosidases Human genes 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 108060008539 Transglutaminase Proteins 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 102000003601 transglutaminase Human genes 0.000 claims description 3
- 102000016938 Catalase Human genes 0.000 claims description 2
- 108010053835 Catalase Proteins 0.000 claims description 2
- 108010008885 Cellulose 1,4-beta-Cellobiosidase Proteins 0.000 claims description 2
- 241000726221 Gemma Species 0.000 claims description 2
- 241000194109 Paenibacillus lautus Species 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 239000007850 fluorescent dye Substances 0.000 claims description 2
- UPSFMJHZUCSEHU-JYGUBCOQSA-N n-[(2s,3r,4r,5s,6r)-2-[(2r,3s,4r,5r,6s)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-(4-methyl-2-oxochromen-7-yl)oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](NC(C)=O)[C@H](OC=2C=C3OC(=O)C=C(C)C3=CC=2)O[C@@H]1CO UPSFMJHZUCSEHU-JYGUBCOQSA-N 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 102000004316 Oxidoreductases Human genes 0.000 claims 1
- 108090000854 Oxidoreductases Proteins 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 150000002978 peroxides Chemical class 0.000 claims 1
- 230000017854 proteolysis Effects 0.000 claims 1
- 229920002477 rna polymer Polymers 0.000 claims 1
- 231100000518 lethal Toxicity 0.000 abstract description 5
- 230000001665 lethal effect Effects 0.000 abstract description 5
- 210000004027 cell Anatomy 0.000 description 90
- 108090000765 processed proteins & peptides Proteins 0.000 description 55
- 102000004196 processed proteins & peptides Human genes 0.000 description 51
- 229920001184 polypeptide Polymers 0.000 description 50
- 108090000623 proteins and genes Proteins 0.000 description 41
- 238000003752 polymerase chain reaction Methods 0.000 description 24
- 230000014509 gene expression Effects 0.000 description 21
- 102000039446 nucleic acids Human genes 0.000 description 16
- 108020004707 nucleic acids Proteins 0.000 description 16
- 150000007523 nucleic acids Chemical class 0.000 description 16
- 239000000463 material Substances 0.000 description 11
- 239000013612 plasmid Substances 0.000 description 11
- 230000001580 bacterial effect Effects 0.000 description 10
- 239000012530 fluid Substances 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 230000010076 replication Effects 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 238000000926 separation method Methods 0.000 description 8
- 238000013518 transcription Methods 0.000 description 8
- 230000035897 transcription Effects 0.000 description 8
- 108010076504 Protein Sorting Signals Proteins 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 108091026890 Coding region Proteins 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000013604 expression vector Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 241000187747 Streptomyces Species 0.000 description 5
- 125000003275 alpha amino acid group Chemical group 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000218636 Thuja Species 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000004520 electroporation Methods 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000003094 microcapsule Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 210000001938 protoplast Anatomy 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 238000013519 translation Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000193747 Bacillus firmus Species 0.000 description 3
- 102000010911 Enzyme Precursors Human genes 0.000 description 3
- 108010062466 Enzyme Precursors Proteins 0.000 description 3
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 229940005348 bacillus firmus Drugs 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000005336 cracking Methods 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 238000003259 recombinant expression Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- HHBBIOLEJRWIGU-UHFFFAOYSA-N 4-ethoxy-1,1,1,2,2,3,3,4,5,6,6,6-dodecafluoro-5-(trifluoromethyl)hexane Chemical compound CCOC(F)(C(F)(C(F)(F)F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)F HHBBIOLEJRWIGU-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 108090000145 Bacillolysin Proteins 0.000 description 2
- 241000605909 Fusobacterium Species 0.000 description 2
- 101100369308 Geobacillus stearothermophilus nprS gene Proteins 0.000 description 2
- 101100080316 Geobacillus stearothermophilus nprT gene Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 241000235403 Rhizomucor miehei Species 0.000 description 2
- 229920001486 SU-8 photoresist Polymers 0.000 description 2
- 241000187432 Streptomyces coelicolor Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 239000005547 deoxyribonucleotide Substances 0.000 description 2
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000001742 protein purification Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- HBZBAMXERPYTFS-SECBINFHSA-N (4S)-2-(6,7-dihydro-5H-pyrrolo[3,2-f][1,3]benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)[C@H]1CSC(=N1)c1nc2cc3CCNc3cc2s1 HBZBAMXERPYTFS-SECBINFHSA-N 0.000 description 1
- GUAHPAJOXVYFON-ZETCQYMHSA-N (8S)-8-amino-7-oxononanoic acid zwitterion Chemical compound C[C@H](N)C(=O)CCCCCC(O)=O GUAHPAJOXVYFON-ZETCQYMHSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 description 1
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 description 1
- 241000534414 Anotopterus nikparini Species 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 108700003918 Bacillus Thuringiensis insecticidal crystal Proteins 0.000 description 1
- 101000775727 Bacillus amyloliquefaciens Alpha-amylase Proteins 0.000 description 1
- 101000695691 Bacillus licheniformis Beta-lactamase Proteins 0.000 description 1
- 108010029675 Bacillus licheniformis alpha-amylase Proteins 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 101100342470 Dictyostelium discoideum pkbA gene Proteins 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 101100385973 Escherichia coli (strain K12) cycA gene Proteins 0.000 description 1
- LLQPHQFNMLZJMP-UHFFFAOYSA-N Fentrazamide Chemical compound N1=NN(C=2C(=CC=CC=2)Cl)C(=O)N1C(=O)N(CC)C1CCCCC1 LLQPHQFNMLZJMP-UHFFFAOYSA-N 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000626621 Geobacillus Species 0.000 description 1
- 101100001650 Geobacillus stearothermophilus amyM gene Proteins 0.000 description 1
- 102000009127 Glutaminase Human genes 0.000 description 1
- 108010073324 Glutaminase Proteins 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 101000882901 Homo sapiens Claudin-2 Proteins 0.000 description 1
- 241000006384 Jeotgalibacillus marinus Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 108010036940 Levansucrase Proteins 0.000 description 1
- 241001282315 Nemesis Species 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 238000009004 PCR Kit Methods 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 241000264435 Streptococcus dysgalactiae subsp. equisimilis Species 0.000 description 1
- 241000194048 Streptococcus equi Species 0.000 description 1
- 101100309436 Streptococcus mutans serotype c (strain ATCC 700610 / UA159) ftf gene Proteins 0.000 description 1
- 241000194054 Streptococcus uberis Species 0.000 description 1
- 241000187392 Streptomyces griseus Species 0.000 description 1
- 102000005158 Subtilisins Human genes 0.000 description 1
- 108010056079 Subtilisins Proteins 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 241001313536 Thermothelomyces thermophila Species 0.000 description 1
- 241000202898 Ureaplasma Species 0.000 description 1
- IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 108010045649 agarase Proteins 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 101150009206 aprE gene Proteins 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 238000005844 autocatalytic reaction Methods 0.000 description 1
- YEJAJYAHJQIWNU-UHFFFAOYSA-N azelastine hydrochloride Chemical compound Cl.C1CN(C)CCCC1N1C(=O)C2=CC=CC=C2C(CC=2C=CC(Cl)=CC=2)=N1 YEJAJYAHJQIWNU-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000003969 blast cell Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 101150005799 dagA gene Proteins 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 108010079502 exoribonuclease T Proteins 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000005816 glass manufacturing process Methods 0.000 description 1
- 108010061330 glucan 1,4-alpha-maltohydrolase Proteins 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 238000007834 ligase chain reaction Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 101150105920 npr gene Proteins 0.000 description 1
- 101150017837 nprM gene Proteins 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 101150019841 penP gene Proteins 0.000 description 1
- 235000020030 perry Nutrition 0.000 description 1
- 230000005622 photoelectricity Effects 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 101150108007 prs gene Proteins 0.000 description 1
- 101150086435 prs1 gene Proteins 0.000 description 1
- 101150070305 prsA gene Proteins 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 101150025220 sacB gene Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000010563 solid-state fermentation Methods 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 229940115922 streptococcus uberis Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 101150052264 xylA gene Proteins 0.000 description 1
- 101150110790 xylB gene Proteins 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1075—Isolating an individual clone by screening libraries by coupling phenotype to genotype, not provided for in other groups of this subclass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1062—Isolating an individual clone by screening libraries mRNA-Display, e.g. polypeptide and encoding template are connected covalently
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
A kind of method for being used for the polynucleotides of identification code enzyme interested in microfluidic devices, this method are carried out by the following:The emulsion of the microfluid drop in the library comprising the polynucleotides for encoding one or more enzymes is provided, it is introduced into allow to expand polynucleotides PCR to the concentration PCR solution in the drop of selection and/or by lethal solution and is introduced into the drop for cancelling selection, and the polynucleotides of identification code enzyme interested.
Description
Technical field
The present invention relates to a kind of microfluid or " chip lab " method.More specifically, it relates to how to use fluid
Inject as a kind of means that selection water droplet is selected or cancelled in immiscible carrier fluid.Water droplet is sometimes referred to as droplet
Or microcapsules, they generally have about 20 microns of average diameter, and are used as compartment or small reaction vessel.They can
With the viable microbial cells containing such as secretase.Drop can also contain other components, such as fluorescent enzyme substrate, the luciferase
Substrate can show the activity of the enzyme as caused by the microbial cell in drop.
Background technology
One of separation coding with desired active gene outcome is described at 1999 (WO 99/02671)
Kind or a variety of genic universals, it comprises the following steps:(a) gene is separated into microcapsules;(b) expression is lost
The factor is passed to produce their own gene outcome in microcapsules;(c) sorting, which produces, has desired active gene
The gene of product.
Have been described and be based on silicone using the vitro expression systems in microcapsules and the chemically inert of stable emulsifying
Surfactant (WO 03/044187).
Such as by applying electric field, the manipulation of droplet is had been realized in, include merging or the coalescence (WO of several drops
2007/089541)。
Many comprehensive surveys can be obtained, and many microfluid components are all commercially available.Microfluidic field is fast
Speed development, and any potential improve all is highly desirable to.
The content of the invention
The inventor of this method is it has been shown that the identification for encoding the polynucleotides of enzyme interested can be in microfluidic device
In effectively carried out by the following:The microfluid in the library comprising the polynucleotides for encoding one or more enzymes is provided
The emulsion of drop, concentration PCR solution is introduced, it allows polynucleotides PCR amplifications into the drop of selectionAnd/orWill be lethal molten
Liquid is introduced into the drop for cancelling selection, then the polynucleotides of identification code enzyme interested.
Correspondingly, the invention provides the method for the polynucleotides of the enzyme interested of identification code in microfluidic devices,
It the described method comprises the following steps:
A) emulsion of the microfluid drop in the library comprising the polynucleotides for encoding one or more enzymes is provided, wherein each
Drop includes the at most single member in library, and expresses the libraries of polynucleotides to produce one or more enzymes;
B) aliquot of the substrate comprising one or more enzymes is introduced into each drop, one or more of which sense is emerging
The presence of the organized enzyme of interest changes into substrate the product that can be screened;
C) determine anti-containing the positive drop for screening product for being higher than predetermined threshold level, the predetermined threshold level
Come over and determine negative drop;
D) aliquot of the concentration PCR solution comprising nucleotides, suitable archaeal dna polymerase and one group of PCR primer is introduced,
It allows to arrive the polynucleotides PCR amplifications for encoding one or more enzymes interested into each positive determined in step (c)
In drop;And/orDNA will be caused to be denatured and the aliquot of enzyme denaturation and/or the solution of cell cracking is introduced in step (c)
In the negative drop of middle determination;
E) polynucleotides of clone or the one or more enzymes interested of PCR amplification codings from positive drop;With
F) from the polynucleotides of the enzyme interested of the polynucleotides identification code in the middle clone of step (e) or PCR amplifications.
Definition
Coded sequence:Term " coded sequence " means the polynucleotides of the amino acid sequence of directly specified polypeptide.Code sequence
The border of row is typically determined that the open reading frame is since initiation codon (such as ATG, GTG or TTG) by open reading frame
And terminated with terminator codon (such as TAA, TAG or TGA).Coded sequence can be genomic DNA, cDNA, synthetic DNA or its
Combination.
Control sequence:The polynucleotides for the mature polypeptide that term " control sequence " means to encode the present invention for expression must
The nucleotide sequence needed.Each control sequence can be natural (that is, from identical for the polynucleotides for encoding the polypeptide
Gene) or external source (that is, from different genes), or be natural or external source relative to each other.Such control sequence includes
But it is not limited to targeting sequencing, polyadenylation se-quence, propeptide sequence, promoter, signal peptide sequence and transcription terminator.Extremely
Few, control sequence includes promoter and transcription and translation termination signal.Be advantageous to for introducing by these control sequences with compiling
The purpose of the specific restriction enzyme enzyme site of the code area connection of the polynucleotides of code polypeptide, these control sequences can be provided with
Multiple joints.
Expression:Term " expression " includes being related to any step caused by polypeptide, including but not limited to transcribes, is repaiied after transcription
Decorations, translation, posttranslational modification and secretion.
Expression vector:Term " expression vector " means wire or ring-shaped DNA molecule, and the molecule includes the multinuclear of coded polypeptide
The control sequence that thuja acid and the polynucleotides are operationally used for its expression with providing is connected.
Host cell:Term " host cell " means to be easy to the nucleic acid construct or table with the polynucleotides comprising the present invention
Up to any cell type of carrier conversion, transfection, transduction etc..The term " host cell " covers the spawn of parental cell,
Due to the mutation occurred during duplication, the offspring and its parental cell are incomplete same.
Separation:Term " separation " means the material being in nature in the form being not present or environment.Separation
The non-limiting examples of material include (1) any non-naturally occurring material, and (2) include but is not limited to any enzyme, variant, core
Acid, protein, any material of peptide or co-factor, the material is at least in part from the one or more with its this qualitative correlation or institute
Have in naturally occurring composition and remove;(3) manually modified any material is passed through relative to the material naturally found;Or (4) are logical
Cross relative to its natural related other components, any material for increasing the amount of material and modifying (such as in host cell
Restructuring produces;Encode multiple copies of the gene of the material;And opened using natural more related than the gene to encoding the material
The stronger promoter of mover).
Nucleic acid construct:Term " nucleic acid construct " means single-stranded or double-stranded nucleic acid molecules, and the nucleic acid molecules are from day
So separated in existing gene, or be modified to include the section of nucleic acid in a manner of being not present in nature originally, or
It is synthesis, the nucleic acid molecules include one or more control sequences.
It is operably connected:Term " being operably connected " means the coded sequence relative to polynucleotides by control sequence
Placement so causes the control sequence to instruct the configuration of the expression of the coded sequence in position.
Sequence identity:Relevance between two amino acid sequences or between two nucleotide sequences passes through parameter
" sequence identity " describes.
For purposes of the present invention, using such as in EMBOSS program bags (EMBOSS:The European Molecular
Biology Open Software Suite[EMBOSS:European Molecular Biology Open software suite], Rice et al., 2000,
Trends Genet. [science of heredity trend] 16:276-277) institute is real in your program of the Maimonides of (preferably 5.0.0 versions or more redaction)
(Needleman and Wunsch, 1970, J.Mol.Biol. [divide Ned Coleman-wunsch (Needleman-Wunsch) algorithm applied
Sub- biology magazine] 48:443-453) determine the sequence identity between two amino acid sequences.Used parameter is empty
The open point penalty 10 in position, gap extension penalties 0.5, and EBLOSUM62 (BLOSUM62 EMBOSS versions) substitution matrix.Will mark
(acquisition of use-non-reduced (nobrief) option), which is exported, for the Maimonides of " most long uniformity " your (Needle) is used as percentage one
Cause property and be calculated as below:
(consistent residue x 100)/(comparing the room sum in length-comparison)
For purposes of the present invention, using such as in EMBOSS program bags (EMBOSS:The European Molecular
Biology Open Software Suite[EMBOSS:European Molecular Biology Open software suite], Rice et al., 2000,
See above) Ned Coleman-wunsch algorithm for being implemented in the Maimonides of (preferably 5.0.0 versions or more redaction) your program
(Needleman and Wunsch, 1970, see above) determine the sequence identity between two deoxyribonucleotide sequences.
Used parameter is Gap Opening Penalty 10, gap extension penalties 0.5, and EDNAFULL (NCBI NUC4.4 EMBOSS
Version) substitution matrix.The Maimonides of " most long uniformity " your (Needle) will be labeled as and export (use-non-reduced (nobrief) option
Obtain) it is used as Percent Identity and is calculated as below:
(consistent deoxyribonucleotide x 100)/(comparing the room sum in length-comparison)
Detailed description of the Invention
In a first aspect, the present invention relates to the polynucleotides of the enzyme interested for identification code in microfluidic devices
Method, it the described method comprises the following steps:
A) emulsion of the microfluid drop in the library comprising the polynucleotides for encoding one or more enzymes is provided, wherein each
Drop includes the at most single member in library, and expresses the libraries of polynucleotides to produce one or more enzymes;
B) aliquot of the substrate comprising one or more enzymes is introduced into each drop, one or more of which sense is emerging
The presence of the organized enzyme of interest changes into substrate the product that can be screened;
C) determine anti-containing the positive drop for screening product for being higher than predetermined threshold level, the predetermined threshold level
Come over and determine negative drop;
D) aliquot of the concentration PCR solution comprising nucleotides, suitable archaeal dna polymerase and one group of PCR primer is introduced,
It allows to arrive the polynucleotides PCR amplifications for encoding one or more enzymes interested into each positive determined in step (c)
In drop;And/orDNA will be caused to be denatured and the aliquot of enzyme denaturation and/or the solution of cell cracking is introduced in step (c)
In the negative drop of middle determination;
E) polynucleotides of clone or the one or more enzymes interested of PCR amplification codings from positive drop;With
F) from the polynucleotides of the enzyme interested of the polynucleotides identification code in the middle clone of step (e) or PCR amplifications.
In a preferred embodiment of the invention, enzyme interested be hydrolase, isomerase, ligase, lyases, oxidation also
Protoenzyme or transferase;Preferably, the enzyme interested be a kind of alpha-galactosidase, alpha-Glucosidase, aminopeptidase, amylase,
Asparaginase, beta galactosidase, β-glucosyl enzym, xylobiase, carbohydrase, carboxypeptidase, catalase, cellobiose
Hydrolase, cellulase, chitinase, cutinase, cyclodextrin glycosyl transferases, deoxyribonuclease, endoglucanase,
Esterase, green fluorescent protein, glucanotransferase, glucoamylase, invertase, laccase, lipase, mannosidase, change are poly-
Carbohydrase, oxidizing ferment, pectin decomposing enzyme, peroxidase, phytase, polyphenol oxidase, proteolytic enzyme, ribalgilase, turn
Glutaminase or zytase.
In yet another preferred embodiment, the library encodes one or more hydrolases, isomerase, ligase, cracking
Enzyme, oxidoreducing enzyme or transferase;Preferably, the library encodes one or more alpha-galactosidases, alpha-Glucosidase, ammonia peptide
Enzyme, amylase, asparaginase, beta galactosidase, β-glucosyl enzym, xylobiase, carbohydrase, carboxypeptidase, hydrogen peroxide
It is enzyme, cellobiohydrolase, cellulase, chitinase, cutinase, cyclodextrin glycosyl transferases, deoxyribonuclease, interior
Cut dextranase, esterase, green fluorescent protein, glucanotransferase, glucoamylase, invertase, laccase, lipase, sweet dew
Glycosidase, become dextranase, oxidizing ferment, pectin decomposing enzyme, peroxidase, phytase, polyphenol oxidase, proteolytic enzyme, core
Ribonuclease T., transglutaminase or zytase.
In a preferred embodiment, the different variants of library coding same enzyme, and in another embodiment, this article
Storehouse includes two or more different polynucleotides of coding same enzyme.
It is contemplated that the method for the present invention can use the polynucleotides of separation and the library of vitro expression systems.However,
The preferred embodiments of the present invention are to set in vivo, and wherein the library is included in prokaryotic host cell;It is preferred that in Gram-positive
In host cell;More preferably in bacillus (Bacillus) host cell;Even more preferably in Alkaliphilic bacillus
(Bacillus alkalophilus), bacillus amyloliquefaciens (Bacillus amyloliquefaciens), bacillus brevis
(Bacillus brevis), Bacillus circulans (Bacillus circulans), Bacillus clausii (Bacillus
Clausii), bacillus coagulans (Bacillus coagulans), bacillus firmus (Bacillus firmus), brilliance
Bacillus (Bacillus lautus), bacillus lentus (Bacillus lentus), bacillus licheniformis (Bacillus
Licheniformis), bacillus megaterium (Bacillus megaterium), bacillus pumilus (Bacillus
Pumilus), bacillus stearothermophilus (Bacillus stearothermophilus), bacillus subtilis (Bacillus
Subtilis) or in bacillus thuringiensis (Bacillus thuringiensis) host cell;And most preferably in lichens
In Bacillus host cell.
Naturally, each single polynucleotides in library are in the single host cell of their own.Correspondingly, preferred real
Apply in example, each drop the first aspect the step of in (a) includes most single host cells.
Enzyme product that is detectable or can quantifying is converted into qualitatively or quantitatively to determine by multinuclear by detecting zymolyte
The activity of one or more enzymes of thuja acid library coding.Generally, fluorescent enzyme substrate is added, is become to be detected or measurement glimmering
Light enzyme product.
Therefore, in a preferred embodiment of the invention, the substrate for one or more enzymes is fluorescence, and the work of enzyme
Fluorogenic substrate is converted into fluorescence-causing substance by property.
Once enzymatic activity of special interest is detected in selected drop, it is necessary to more in drop to be identified
Nucleic acid libraries member.Generally, polynucleotides are identified by DNA sequencing.
When building library, polynucleotides may be fitted with identifying sequence label for use as " bar code ", so as to exclude
The needs of sequencing.Identification based on bar code, will immediately know that the DNA sequence dna of polynucleotides, therefore be identified.
The present invention preferred aspect, by the DNA sequencing of polynucleotides in step (f) identification code enzyme interested
Polynucleotides.
In the first aspect of the present invention, several aliquots of solution are introduced into drop.The volume of aliquot is usual
It is more much smaller than drop, but their size in principle can be equal with the volume of drop even more big.In the following example, etc.
Divide sample significantly less than drop.Aliquot is introduced into drop in microfluidic devices or said two drops in another way
Merge or the method for coalescence there are many kinds.
Such as disclosed in WO 2007/061448 and can apply electric field to merge or coalesce two or more drops
Microfluidic device design.Another method that the small aliquot of waterborne liquid is introduced into water droplet in microfluidic devices
It is referred to as " micro-injection ", and has disclosure in such as WO 2010/151776.
In the following example, aliquot and droplet coalescence or coalescence are introduced aliquot by applying electric field
In drop.
Correspondingly, in the preferred embodiment of first aspect, by applying electric field or by injecting aliquot and liquid
Drop merges or aliquot is incorporated into drop by coalescence.
Polynucleotides
The invention further relates to the library for the polynucleotides for encoding one or more enzyme polypeptides as described herein.
Technology for separating or cloning polynucleotides is well known in the art, and including from genomic DNA or
CDNA, or its combination separation.Can be for example by using well known polymerase chain reaction (PCR) or the antibody screening of expression library
To detect the cloned DNA fragments with apokoinou construction feature, realize from genomic dna cloning polynucleotides.See, for example,
Innis et al., 1990, PCR:A Guide to Methods and Application[PCR:Methods and applications guide],
Academic Press [academic press], New York.Other amplification procedures such as ligase chain reaction can be used
(LCR) activated transcription (LAT) and the amplification (NASBA) based on polynucleotides, are connected.
Encoding the modifications of the polynucleotides of polypeptide of the present invention the polypeptide of the polypeptide is substantially similar to for synthesis to be
It is required.Term " is substantially similar to " the non-naturally occurring form that the polypeptide refers to the polypeptide.These polypeptides can be because of certain
Kind of engineered way and the polypeptide from being separated from its natural origin is different, such as in specific activity, heat endurance, optimal pH etc.
Different variants.Variant can be constructed as below:It is more based on being proposed as mature polypeptide encoded sequence (for example, its subsequence)
Nucleotides, and/or by introducing nucleotide subsitution, the nucleotide subsitution does not cause the amino acid sequence of polypeptide to change, still
Used corresponding to the codon for being intended to the host organism for producing enzyme, or different aminoacids sequence can be produced by introducing
Nucleotide subsitution.For the general description of nucleotides substitution, see, e.g. Ford et al., 1991, Protein Expression
And Purification [protein expression and purifying] 2:95-107.
Nucleic acid construct
The invention further relates to nucleic acid construct, these nucleic acid constructs include being operably coupled to one or more controls
The polynucleotides of the invention of sequence, under conditions of compatible with control sequence, this or these control sequence instructs code sequence
The expression being listed in suitable host cell.
Can be with polynucleotides described in multi-mode operation perhaps in order to the expression of polypeptide.Depending on expression vector, in multinuclear
It can be desirable or required that manipulation is carried out to it before thuja acid insertion vector.For being modified using recombinant DNA method
The technology of polynucleotides is well known in the art.
The control sequence can be promoter, i.e. be identified by host cell with the polynucleotides to encoding polypeptide of the present invention
The polynucleotides expressed.The promoter includes transcriptional control sequence, and these sequences have mediated the expression of the polypeptide.The startup
Son can be any polynucleotides that transcriptional activity is shown in host cell, including saltant type, truncated-type and heterozygous open
Mover, and can be obtained by encoding with homologous or heterologous extracellular or intracellular polypeptides the gene of the host cell.
The example of suitable promoter for the transcription for the nucleic acid construct that the present invention is instructed in bacterial host cell is
The promoter obtained from following gene:Bacillus amyloliquefaciens alpha-amylase gene (amyQ), bacillus licheniformis alpha-starch
Enzyme gene (amyL), bacillus licheniformis penicillinase gene (penP), bacillus stearothermophilus production maltogenic amylase base
Because of (amyM), subtilis levansucrase gene (sacB), bacillus subtilis xylA and xylB gene, Su Yunjin
Bacillus cryIIIA genes (Agaisse and Lereclus, 1994, Molecular Microbiology [molecular microbiology]
13:97-107), E. coli lac operon, Escherichia coli trc promoters (Egon et al., 1988, Gene [genes] 69:
301-315), streptomyces coelicolor agarase gene (dagA) and protokaryon beta-lactam enzyme gene (Villa-Kamaroff
Et al., 1978, Proc.Natl.Acad.Sci.USA [NAS's proceedings] 75:3727-3731) and tac starts
Sub (DeBoer et al., 1983, Proc.Natl.Acad.Sci.USA [NAS's proceedings] 80:21-25).
Gilbert et al. (1980) Scientific American [science American], 242:" Useful in 74-94
In proteins from recombinant bacteria " [the useful proteins matter from recombinant bacteria];And
Sambrook et al. describes other promoter in (1989, see above).The example of Gene expression is disclosed in WO 99/
In 43835.
Control sequence, which can also be, to be identified by host cell to terminate the transcription terminator of transcription.Terminator is more with encoding this
3 '-end of the polynucleotides of peptide is operably connected.Any terminator of functional can be used for this hair in host cell
In bright.
The preferred terminator of bacterial host cell obtains from the gene for the following:Bacillus clausii alkalescence egg
White enzyme (aprH), bacillus licheniformis alpha-amylase (amyL) and Escherichia coli rRNA (rrnB).
Control sequence can also be the stable sub-districts of the mRNA of the upstream of coding sequence of promoter downstream and gene, and it increases should
The expression of gene.
The example of the stable subregions of suitable mRNA obtains from following:Bacillus thuringiensis cryIIIA genes (WO
94/25612) (Hue et al., [bacteriology is miscellaneous by 1995, Journal of Bacteriology with bacillus subtilis SP82 genes
Will] 177:3465-3471).
Control sequence can also be that coding is connected the secretion path for and guiding polypeptide to enter cell with the N- ends of polypeptide
The signal peptide coding region of signal peptide.The 5 ' of the coded sequence of polynucleotides-end can be inherently included in translation reading frame in
The signal coding sequence that the section of the coded sequence of coded polypeptide natively connects.Alternately, the 5 ' of coded sequence-end
It is external signal coding sequence that can include relative to coded sequence.Do not encoded in coded sequence comprising signal peptide natively
In the case of sequence, it may be necessary to extraneous signal peptide-coding sequence.Alternately, extraneous signal peptide-coding sequence can be merely
Natural signals peptide-coding sequence is substituted to strengthen the secretion of polypeptide.However, it is possible to use guidance has expressed polypeptide and has entered host
Any signal coding sequence of the secretory pathway of cell.
Useful signal peptide-coding sequence for bacterial host cell is formed sediment from the Fructus Hordei Germinatus of bacillus NCIB 11837 sugar
Powder enzyme, bacillus licheniformis subtilopeptidase A, Di clothing Ya spore Gan Jun Calcium-lactamase, the fatty Ya spores Gan Jun Ru-shallow lake of Shi heat
What the gene of powder enzyme, stearothermophilus neutral protease (nprT, nprS, nprM) and bacillus subtilis prsA obtained
Signal coding sequence.Simonen and Palva, 1993, Microbiological Reviews [microorganism comment] 57:109-
137 describe other signal peptide.
Control sequence can also be the propeptide code sequence of propetide of the coding at peptide N-terminus.The polypeptide quilt of generation
Referred to as preemzyme (proenzyme) or propolypeptide (or being referred to as proenzyme (zymogen) in some cases).Propolypeptide is typically
It is inactive and the propetide from propolypeptide can be cut by catalysis cutting or autocatalysis to be converted into active peptides.Can
With from bacillus subtilis alkali proteinase (aprE), Bacillus subtilis neutral protease (nprT), thermophilic fungus destroyed wire
(Myceliophthora thermophila) laccase (WO 95/33836), rhizomucor miehei (Rhizomucor miehei) day
The gene of winter serine protease and cerevisiae alpha-factor obtains propeptide code sequence.
In the presence of signal peptide sequence and propeptide sequence, the propeptide sequence is located immediately adjacent the N- of polypeptide
End and the signal peptide sequence are located immediately adjacent the N- ends of the propeptide sequence.
It may also it is desirable to add regulatory sequence, the regulatory sequence regulation is relative to the growth of host cell
The expression of polypeptide.The example of regulatory sequence is so that the expression of gene in response to chemical or physical stimulus (including modulating compound
Presence) and be turned on and off those.Regulatory sequence in prokaryotic system includes lac, tac and trp operon system.Adjust
Other examples of section sequence are those for allowing gene magnification.
Expression vector
The invention further relates to the restructuring of the polynucleotides comprising the present invention, promoter and transcription and translation termination signal
Expression vector.Different nucleotides and control sequence can link together to produce recombinant expression carrier, and the recombination expression carries
Body can include one or more convenient restriction sites to allow to insert or substitute at these sites to encode the polypeptide
Polynucleotides.Alternately, the polynucleotides can be by by the polynucleotides or nucleic acid construct including the polynucleotides
Body is inserted in the suitable carrier for expression to express.When producing the expression vector, the coded sequence is located in the carrier, this
Sample causes the suitable control sequence that the coded sequence is used to express with this to be operably connected.
Recombinant expression carrier can be can advantageously be subjected to recombinant DNA program and can cause polynucleotides express it is any
Carrier (for example, plasmid or virus).The selection of carrier will typically depend on the carrier with there is the host of the carrier to be introduced thin
The compatibility of born of the same parents.The carrier can be linear or closure circular plasmids.
Carrier can be autonomously replicationg vector, i.e. as carrier existing for extrachromosomal entity, it is replicated independently of dyeing
Body replicates, for example, plasmid, extra-chromosomal element, minichromosomes or artificial chromosome.The carrier, which can include, to be used to ensure self
Any device replicated.Alternately, the carrier can be such carrier, when it is introduced into the host cell, be integrated
Replicated into genome and together with the one or more chromosomes for wherein having incorporated it.In addition it is possible to use single load
(these carriers or plasmid jointly comprise the gene to be introduced into host cell for body or plasmid or two or more carriers or plasmid
STb gene in group) or transposons.
The carrier, which preferably comprises one or more, to be allowed easily to select transformed cells, transfectional cell, transducer cell etc. thin
The selective key thing of born of the same parents.Selective key thing is such a gene, the product of the gene provide biocide resistance or
Virus resistance, heavy metal resistance, auxotrophic prototrophy etc..
The example of bacillary selected marker is bacillus licheniformis or bacillus subtilis dal genes, or assigns antibiosis
The mark of plain resistance (such as ampicillin, chloramphenicol, kanamycins, neomycin, spectinomycin or tetracyclin resistance).
Carrier preferably comprise allow vector integration into the genome of host cell or carrier in cell independently of gene
The element of group autonomous replication.
For being incorporated into the host cell gene group, the carrier can rely on encode the polypeptide polynucleotide sequence or
Person is used for any other element by homologous or non-homologous re-combination to the carrier in the genome.Alternately, should
Carrier, which can include, to be used to instruct to be incorporated into one or more of host cell gene group chromosome by homologous recombination
One or more exact positions other polynucleotides.In order to increase the possibility integrated in exact position, these integration
Element should include sufficient amount of nucleic acid, such as 100 to 10,000 base-pair, 400 to 10,000 base-pair and
800 to 10,000 base-pair, the sequence identity that these base-pairs have height with corresponding target sequence are homologous heavy to improve
The possibility of group.These integrated elements can be the homologous any sequence of the target sequence in the genome with host cell.In addition,
These integrated elements can be non-coding polynucleotide or coded polynucleotide.On the other hand, the carrier can be by non-same
Source recombination and integration is into the genome of host cell.
For autonomous replication, carrier, which may further include, enables the carrier independently multiple in the host cell discussed
The replication orgin of system.Replication orgin can be any plasmid replicon of the mediation autonomous replication to be worked in cell.Term
" replication orgin " or " plasmid replicon " means the polynucleotides for enabling plasmid or carrier to replicate in vivo.
The example of bacterial origin of replication be allow replicated in Escherichia coli pBR322 plasmid, pUC19, pACYC177,
And pACYC184 replication orgin, and allow replicated in bacillus plasmid pUB110, pE194, pTA1060,
And pAM β 1 replication orgin.
The more than one copy Insertion Into Host Cell of polynucleotides of the present invention can be increased the generation of polypeptide.Pass through
At least one other copy of sequence is incorporated into host cell gene group or by comprising together with the polynucleotides
Amplifiable selected marker can obtain the increased copy numbers of polynucleotides, wherein by appropriate selection
Property reagent in the presence of culture cell can select the cell and thus of the copy through amplification comprising selected marker
The other copy of the polynucleotides.
To build the program of recombinant expression carrier of the present invention it is the general of this area for connecting element described above
Known to logical technical staff (see, e.g., Sambrook et al., 1989, see above).
Host cell
The invention further relates to recombinant host cell, these recombinant host cells include the polynucleotides of the present invention, the multinuclear
Thuja acid is operably coupled to one or more control sequences, and one or more control sequences instruct the production of the polypeptide of the present invention
It is raw.Construct including polynucleotides or carrier are introduced into host cell, so that the construct or carrier are maintained work
For chromosomal integrant or as carrier outside the chromosome of autonomous replication, as noted earlier.Term " host cell " cover due to
The spawn of the mutation that occurs in the reproduction process parental cell different from parental cell.The selection of host cell is in very great Cheng
Depend on encoding gene and its source of the polypeptide on degree.
Host cell can have any cell for recombinating the polypeptide for producing the present invention, such as prokaryotic.
Prokaryotic host cell can be any Gram-positive or gramnegative bacterium.Gram-positive bacterium include but
It is not limited to:Bacillus, fusobacterium, enterococcus spp, Geobacillus, lactobacillus, lactococcus, bacillus marinus
Category, staphylococcus, streptococcus and streptomyces.Gramnegative bacterium includes but is not limited to:It is campylobacter, big
Enterobacteria, Flavobacterium, Fusobacterium, Helicobacterium, mud Bacillus, eisseria, Pseudomonas, Salmonella,
And Ureaplasma.
Bacterial host cell can be any bacillus cell, include but is not limited to:Alkaliphilic bacillus, solution starch
It is bacillus, bacillus brevis, Bacillus circulans, Bacillus clausii, bacillus coagulans, bacillus firmus, bright
Rotten bacillus, bacillus lentus, bacillus licheniformis, bacillus megaterium, bacillus pumilus, stearothermophilus gemma bar
Bacterium, bacillus subtilis and Bacillus thuringiensis cell.
Bacterial host cell can also be any streptococcus cell, include but is not limited to:Streptococcus equisimilis, make purulence hammer
Bacterium, streptococcus uberis and streptococcus equi subsp blast cells.
Bacterial host cell can also be any Streptomyces cell, include but is not limited to:Not streptomyces chromogenes, deinsectization chain
Mould, streptomyces coelicolor, streptomyces griseus and shallow Streptomyces glaucoviolaceus cell.
DNA is introduced into bacillus cell and can be realized by following:Protoplast transformation is (see, for example, Chang
And Cohen, 1979, Mol.Gen.Genet. [molecular genetics and genomics] 168:111-115), competent cell converts
(see, e.g., Young and Spizizen, 1961, J.Bacteriol. [Bacteriologies] 81:823-829;Or Dubnau with
And Davidoff-Abelson, 1971, J.Mol.Biol. [J. Mol. BioLs] 56:209-221), electroporation is (referring to example
Such as, Shigekawa and Dower, 1988, Biotechniques [biotechnologys] 6:742-751) or engagement (see, e.g.
Koehler and Thorne, 1987, J.Bacteriol. [Bacteriologies] 169:5271-5278).DNA is introduced into Escherichia coli
It can be realized in cell by following:Protoplast transformation (see, e.g., Hanahan, 1983, J.Mol.Biol., [give birth to by molecule
Thing magazine] 166:557-580) or electroporation is (see, e.g., Dower et al., 1988, Nucleic Acids Res. [cores
Acid research] 16:6127-6145).DNA is introduced into Streptomyces cell and can be realized by following:Protoplast transformation, electricity
Perforation is (see, for example, Gong et al., 2004, Folia Microbiol. [microorganism grand sight] (Praha (Prague)) 49:
399-405), engagement is (see, for example, Mazodier et al., 1989, J.Bacteriol. [Bacteriologies] 171:3583-
3585) or transduction is (see, for example, Burke et al., 2001, Proc.Natl.Acad.Sci.USA [PNASs]
98:6289-6294).DNA is introduced into pseudomonas cell and can be realized by following:Electroporation is (see, e.g., Choi
Et al., 2006, J.Microbiol.Methods [micro-biological process magazines] 64:391-397) or engagement (see, e.g.,
Pinedo and Smets, 2005, Appl.Environ.Microbiol. [application and environmental microbiologies] 71:51-57).By DNA
Being introduced into streptococcus cell can be realized by following:Natural competence (see, e.g., Perry and Kuramitsu,
1981, Infect.Immun. [infection is with being immunized] 32:1295-1297), protoplast transformation (see, e.g., Catt and
Jollick, 1991, Microbios [microbiologies] 68:189-207), electroporation (see, e.g., Buckley et al.,
1999, Appl.Environ.Microbiol. [application and environmental microbiologies] 65:3800-3804) or engagement (referring to,
For example, Clewell, 1981, Microbiol.Rev. [Microbis] 45:409-436).However, it is possible to use this area
Known any method that DNA is introduced to host cell.
Production method
The invention further relates to the method for producing polypeptide of the present invention, this method includes:(a) in the bar for being beneficial to produce the polypeptide
The recombinant host cell of the present invention is cultivated under part;And optionally, (b) reclaims the polypeptide.
These host cells are in being adapted for use with method as known in the art and producing the nutrient medium of the polypeptide
Culture.For example, can by Shaking culture or laboratory or industrial fermentation tank middle and small scale or large scale fermentation (including
Continuously, in batches, fed-batch or solid state fermentation) culture cell, the culture is in suitable culture medium and is allowing to express
And/or carried out under conditions of isolated polypeptide.The culture is to use program as known in the art, in a kind of suitable nutrient medium
Middle generation, the culture medium include carbon and nitrogen source and inorganic salts.Suitable culture medium can obtain from commercial supplier or can root
Prepared according to disclosed composition (for example, in catalogue of American type culture collection).If polypeptide is secreted into the battalion
Support in culture medium, then polypeptide can be directly reclaimed from culture medium.If polypeptide is not secreted, then it can be from cell pyrolysis liquid
Reclaimed.
Using specificity the polypeptide can be detected for the methods known in the art of the polypeptide.These detection method bags
Include but be not limited to, the use of specific antibody, the formation of enzyme product or the disappearance of zymolyte.It is, for example, possible to use enzymatic determination comes
Determine the activity of the polypeptide.
Polypeptide can be reclaimed using methods known in the art.For example, (it can be included but is not limited to by conventional program
Collection, centrifuge, filter, extract, be spray-dried, evaporate or precipitate) reclaim the polypeptide from the nutrient medium.In one aspect,
Recovery includes the zymotic fluid of the polypeptide.
Can by a variety of method purified polypeptides known in the art, methods described include but is not limited to chromatography (for example,
Ion-exchange chromatography, affinity chromatography, hydrophobic chromatography, focusing chromatography and size exclusion chromatography method), electrophoresis method (example
Such as, preparative isoelectric focusing), otherness dissolving (for example, ammonium sulfate precipitation), SDS-PAGE or extraction (see, e.g.,
Protein Purification [protein purification], editing Janson and Ryden, VCH Publishers, [VCH publishes public
Department], New York, 1989), to obtain substantially pure polypeptide.
Example
The microfluidic device of example 1.
Use soft lithography (Duffy, D.;McDonald,J.;Schueller,O.;Whitesides,G.;
Anal.Chem. [analytical chemistry] 1998,70,4974-4984) by being poly- (dimethyl siloxane) (PDMS) by passage imitation
To manufacture microfluidic device.In short, pass through the ultraviolet of mask (Selba SA [Sai Erba companies], Wei Er Suvas of Switzerland)
Expose (MJB3 contact mask aligners;Germany plus emerging Su Si Microtechnologies Inc. (SUSS MicroTec, Garching,
)) and subsequent development (SU-8 developers Germany;Microchem Corp. (MicroChem Corp.)) silicon chip (French Ah
Your SILTRONIX companies (SILTRONIX, Archamp, France) still) on manufacture SU-8 photoresists (Massachusetts
Microchem Corp. (MicroChem Corp., Newton, MA) of newton) mould.By curing agent add PDMS substrates (184 silicone elastomer kits;Lyons, France Dow Corning Corporation (Dow Corning Corp., Lyon,
France to final concentration 10% (v/v), mixing in)), and it is poured on mould up to 5mm depth.After about 12h is crosslinked at 65 DEG C,
PDMS is peeled off from mould, the HARRIS UNI-CORE of input and output port 0.75mm diametersTMBiopsy stamping machine punching press
(Pennsylvania's Heartfield electron microscope company (Electron Microscopy Sciences,
Hatfield,PA)).Using pressurized nitrogen PDMS particles are removed from port.By the way that two parts are exposed into oxygen plasma
(PLASMA PREPTMII plasma furnaces;German Ahmedabad applies Wa Erbahe Jia La instruments company limited by shares (GaLa
Instrumente GmbH, Bad Schwalbach, Germany)) and press them together, by the structuring of PDMS slabs
Side is attached to 76 × 26 × 1mm glass microscope slide (the Borrow Malin Fei Er of Lauda, Germany-Konigshofen
Moral company (Paul Marienfeld GmbH&Co.KG, German on)).Finally, dredged with business
Aqueous surface coating agent (The Pittsburg glassmaking company of Pennsylvania Pittsburg
(Pittsburgh Glassworks Industries)) coating unit, is then rinsed with N2.Inject/take using normal pressure
Go out the syringe pumps of PHD 22/2000 (German Nie Moxisi Cetoni companies (Cetoni, Nemesis, Germany)) by liquid pump
Enter in microfluidic device.
The formation of the emulsion of example 2.
Emulsion can produce from many suitable combinations of immiscible liquid.The emulsion of the present invention has with separator well
Drop form existing for aqueous phase (water containing biochemistry and biological components) and as suspending drops in carrier therein
The commercially available hydrophobicity of fluid, immiscible liquid (contain 2% (w/w) PICO-SURFTMSurfactant (Britain Camb
Spheroid fluidics company (Sphere Fluidics, Cambridge, UK)) HFE-7500 fluorinated oils).Such emulsion claims
For Water-In-Oil (W/O).Emulsion is by the presence of surfactant and stable.
The generation of emulsion needs to apply mechanical energy to force two to be combined together.Exist various using different
The method of mechanical device can do this part thing.We have used the microfluidic device or chip of referred to as droplet generator, its
Force two to communicate meticulous nozzle, thus produce the single dispersing drop of Water-In-Oil.Such generator can be when very short
Interior to produce substantial amounts of drop, its speed measures in the range of kHz.
Form the drop of the chloramphenicol growth medium containing Luria Bertani (LB), growth medium supplement
There is the solution that expression encodes the B. subtilis cell of the gene library of a variety of amylase variants.Cell is diluted so that system
Meter is packaged into often on learning according to Poisson distribution (Poisson distribution), no more than one B. subtilis cell
In individual drop.The cell concentration used in this experiment only allows about 34% drop to be occupied by (single) bacterium, leaves emulsion
In close to 66% drop do not have any living cells.
Total aqueous phase (bacterial cell with low concentration) is loaded into PTFE tube and (0.56 × 1.07mm inside/outsides footpath, flies generation that
Bioblock scientific & technical corporation (Fisher Bioblock Scientific)) in, and connect the tubing on syringe.Use injection
Aqueous phase is expelled in droplet generator microfluidic device by pump with 100 μ L/h flow velocity.Gained liquid is passed through with 250 μ L/h flow velocity
Flow with the flow focusing of above-mentioned carrier fluid to produce drop.It is 5kHz that drop, which produces speed,.Therefore, about 200.000 are encapsulated
To provide about 600.000 drops, it is (wherein most that each drop statistically includes an at most individual cells in the library of bacterium
Number drop is empty).Gained emulsion is stored in syringe 8 hours to allow bacterial growth and allow in drop at 37 DEG C
Amylase produce and secretion.
Example 3. injects amylase substrate to detect enzymatic activity
After emulsion is incubated overnight, it is expelled in another microfluidic device again with 20 μ L/h speed, drop
It is spaced apart with the carrier fluid injected with 120 μ L/h.Into each drop, addition small size (about 20% droplet size) can
Commercially available fluorescence amylase substrate (ENZCHEKTMDetermination of amylase kit E33651, Life Technologies, Inc. (Life
Technologies)).Continuous substrate is mutually injected/is fused to so that substrate to be added in drop in drop by voltolisation knot, with
Realize the ultimate density of the about 25 μ g/L substrates in each drop in the PBS that pH is 7.By using model 623b high pressures
Amplifier (Te Ruike companies (Trek, Inc.);BF:OPTILAS SAS, Britain Camb) apply 600 volts under 30kHz between electrode
Spy's exchange (AC) electric field, drop are merged with per second about 2 with substrate phase, and the speed of 000 fusion event is carried out 30 minutes.For
200.000 initial cells in 600.000 drops each provide substrate, and all drops are collected in syringe again
In, then it is incubated 30 minutes at room temperature, so that amylase and the substrate reactions in drop.
Example 4. cracks selection amylase variant by cell
Drop incubation after, emulsion is expelled in another microfluidic device again with 20 μ L/h, and with 120 μ L/h
Carrier fluid be spaced apart.When laser beam of the drop by 488nm excitation wavelengths, the fluorescence of all 600.000 drops is used
Photomultiplier (PMT) measures.Do not show that the drop of fluorescence signal (therefore shows not have in drop living cells or only point
Secrete the cell of nonactive amylase variant) lethal KOH/EDTA solution is injected using electric Agglomeration methods same as described above.
Depending on the fluorescence signal detected from each drop, electric field is opened and closed.By the molten of 400mM KOH and 10mM EDTA
Liquid is expelled in these negative drops, to realize 200mM KOH and 5mM EDTA ultimate density.The KOH of injection is in negative fluid
Quickly mixed in drop, exist side by side and dissolve any cell therein, and make any protein or nucleic acid denaturation, so that negative fluid
The content of drop prepares to be dropped.On the other hand, the positive drop of fluorescence signal is shownNoIt is injected lethal solution.It is positive
Can also physical separation and separation from negative drop, then collect, but in this example, we are simply by lethal injection
To cancel the negative drop of selection.
Cancel select after, we by add 10 μ L PICO-BREAKTM(the spheroid fluidics of Britain Camb is public
Department (Sphere Fluidics, Cambridge, UK)) and 10mL fresh growth mediums destroy emulsion.From positive liquid
The remaining bacillus cell of drop is not influenceed by the KOH from the drop for cancelling selection and EDTA, because gathering in all drops
After knot, KOH/EDTA concentration has been diluted million times.Resulting solution (Innova 400, is flown into generation that at 37 DEG C with 220rpm
Scientific & technical corporation (Fisher scientist)) oscillation incubation is overnight to allow bacterial growth.
The selection that example 5. passes through PCR
As alternative choosing principles, we also carry out Direct PCR in positive drop, as follows:Repeat example 2-3 journey
Sequence, but in example 3 after the final incubation of drop, by emulsion be expelled to again in new microfluidic device with 20 μ L/h and with
Contain 2%w/w with 120 μ L/hSurfactant (the spheroid fluidics company (Sphere in Cambridge
Fluidics, Cambridge)) HFE-7500 fluorinated oils be spaced apart.When drop is by a 488nm laser spots, photoelectricity is used
Multiplier tube (PMT) measures the fluorescence of each drop.Each positive to showing the fluorescence signal higher than specific predetermined background level
Droplet injection PCR solution.We use the continuous phase of the PCR reaction solutions containing 10 times of concentrations, PCR reaction solutions use
KAPA HiFi HotStart ReadyMix PCR kits (KK2606, Life Technologies, Inc. (Life technologies))
With the specific primer of each amylase gene amplification in 3 μM of concentration.Using electric field consecutive PCR is injected for each positive drop
Phase.Afterwards, the primer and 1 times of PCR that each drop contains ultimate density 300nM amylase encoding gene specific amplification mix
Thing.The negative drop of fluorescence signal does not inject PCR solution needed for not showing.The activation that is injected through of continuous phase PCR solution applies
The pulses of 1000V High Level AC Voltages (AC) on the electrode of neighbouring continuous aqueous phase is carried out.Depending on being examined from each drop
The fluorescence signal measured, open and close electric field.
After selection, reclaim emulsion and be placed in thermal cycler, performing PCR is entered to emulsion.PCR reactions are carried out at 95 DEG C
3min, then at 98 DEG C, 20s;65 DEG C, 20s;With 72 DEG C, under 1.5min carry out 30 circulation, final incubation step be at 72 DEG C
Lower carry out 5min.
After thermal cycle, by adding 10 μ L's(the spheroid fluidics company of Britain Camb
(Sphere fluidics, Cambridge, UK)) emulsion is destroyed and by droplet coalescence.Pass through the phase between aqueous phase and oil phase
Separate and recover aqueous phase.Only show that the amylase of fluorescence signal and the drop with being injected PCR mixtures and primer encodes base
Because being amplified.
The sequence of positive hit can be identified by any suitable standard method, such as by cloning and being sequenced gene
Or directly surveyed by using the sequencing primer of system marks in so-called " (NextGeneration) of future generation " sequencing equipment
Sequence gene, as example disclosed in WO 2012/019765.
The use of the primer of biotin labeling is probably favourable in PCR solution.This will allow to use for example with strepto-
The chromatographic column of Avidin rapidly and easily reclaims the PCR primer of amplification.
The microfluid of example 6. is equipped
Can use includes the microfluidic device of more than one syringe on same device so that drop interested can
With from many different fluid rapid fusions.This will allow to sort the drop with positive signal into the storehouse of varying number, example
Such as by intensity or its fluorescence return signal, i.e. enzymatic activity determines.This can be mixed by using the different PCR containing different primers
Composition injection is dripped to carry out.Each storehouse can be defined by specific fluorescent strength range.This will allow based on different threshold values
Drop selects.The selection in storehouse is by the level depending on the fluorescence signal from drop.Every group of primer in each syringe can be with
Unique tags sequence with the storehouse for identifying quantity identical with syringe.For example, the device with three syringes will allow with
Three fractions sort emulsion.By this way, each fraction can inject different groups of labeled primer to indicate that original host is thin
The enzyme activity level (phenotype) of born of the same parents.
Claims (10)
1. a kind of method for being used for polynucleotides of identification code enzyme interested in microfluidic devices, methods described include with
Lower step:
A) emulsion of the microfluid drop in the library comprising the polynucleotides for encoding one or more enzymes is provided, wherein each drop
At most single member comprising the library, and the libraries of the polynucleotides is expressed to produce one or more enzymes;
B) aliquot of the substrate comprising one or more enzymes is introduced into each drop, one or more of which is interested
The presence of organized enzyme the substrate is changed into the product that can be screened;
C) the positive drop for screening product containing higher than predetermined threshold level is determined, the predetermined threshold level is in turn
The negative drop is determined again;
D) aliquot of the concentration PCR solution comprising nucleotides, suitable archaeal dna polymerase and one group of PCR primer is introduced, it is permitted
The polynucleotides PCR amplifications for encoding one or more enzyme interested are arrived to each positive determined in step (c) perhaps
In drop;And/or the aliquot for the solution that DNA is denatured and enzyme denaturation and/or cell crack will be caused to introduce in step (c)
In the negative drop of middle determination;
E) polynucleotides of clone or PCR amplification codings one or more enzyme interested from the positive drop;With
F) polynucleotides of the polynucleotides identification code of the clone from step (e) or PCR amplifications enzyme interested.
2. the method as described in claim 1, the wherein enzyme interested are hydrolase, isomerase, ligase, lyases, oxygen
Change reductase or transferase;Preferably, the enzyme interested is a kind of alpha-galactosidase, alpha-Glucosidase, aminopeptidase, starch
Enzyme, asparaginase, beta galactosidase, β-glucosyl enzym, xylobiase, carbohydrase, carboxypeptidase, catalase, fiber
Disaccharide-hydrolysing enzymes, cellulase, chitinase, cutinase, cyclodextrin glycosyl transferases, deoxyribonuclease, inscribe Portugal gather
Carbohydrase, esterase, green fluorescent protein, glucanotransferase, glucoamylase, invertase, laccase, lipase, mannosidase,
Become dextranase, oxidizing ferment, pectin decomposing enzyme, peroxidase, phytase, polyphenol oxidase, proteolytic enzyme, ribonucleic acid
Enzyme, transglutaminase or zytase.
3. method as claimed in claim 1 or 2, the wherein library encode one or more hydrolases, isomerase, ligase,
Lyases, oxidoreducing enzyme or transferase;Preferably, the library encode one or more alpha-galactosidases, alpha-Glucosidase,
Aminopeptidase, amylase, asparaginase, beta galactosidase, β-glucosyl enzym, xylobiase, carbohydrase, carboxypeptidase, peroxide
Change hydrogen enzyme, cellobiohydrolase, cellulase, chitinase, cutinase, cyclodextrin glycosyl transferases, DNA
Enzyme, endoglucanase, esterase, green fluorescent protein, glucanotransferase, glucoamylase, invertase, laccase, lipase,
Mannosidase, become dextranase, oxidizing ferment, pectin decomposing enzyme, peroxidase, phytase, polyphenol oxidase, proteolysis
Enzyme, ribalgilase, transglutaminase or zytase.
4. the method as any one of preceding claims, the wherein library encode the different variants of same enzyme.
5. the method as any one of preceding claims, the wherein library include two or more of coding same enzyme
Different polynucleotides.
6. the method as any one of preceding claims, the wherein library are comprised in prokaryotic host cell;It is preferred that
In gram positive host cell;More preferably in Bacillus host cell;Even more preferably in Alkaliphilic bacillus, solution
Bacillus amyloliquefacienses, bacillus brevis, Bacillus circulans, Bacillus clausii, bacillus coagulans, hard gemma bar
Bacterium, bacillus lautus, bacillus lentus, bacillus licheniformis, bacillus megaterium, bacillus pumilus, stearothermophilus
In bacillus, bacillus subtilis or bacillus thuringiensis host cell;And most preferably in bacillus licheniformis host
Into the cell.
7. method as claimed in claim 7, wherein each drop in step (a) includes at most single host cell.
8. the substrate of the method as any one of preceding claims, wherein one or more enzymes is fluorescence, and
And the fluorogenic substrate is converted into fluorescence-causing substance by the activity of the wherein enzyme.
9. the method as any one of preceding claims, the polynucleotides of wherein coding enzyme interested are more by this
The DNA sequencing of nucleotides is accredited in step (f).
10. the method as any one of preceding claims, the wherein aliquot are by applying electric field or passing through injection
The aliquot and the droplet coalescence or coalescence are introduced into the drop.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15160072.3 | 2015-03-20 | ||
EP15160072 | 2015-03-20 | ||
PCT/EP2016/055577 WO2016150771A1 (en) | 2015-03-20 | 2016-03-15 | Droplet-based selection by injection |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107406889A true CN107406889A (en) | 2017-11-28 |
CN107406889B CN107406889B (en) | 2021-11-02 |
Family
ID=52686270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201680016459.8A Active CN107406889B (en) | 2015-03-20 | 2016-03-15 | Droplet-based selection by injection |
Country Status (5)
Country | Link |
---|---|
US (1) | US10883102B2 (en) |
EP (1) | EP3271477B1 (en) |
CN (1) | CN107406889B (en) |
DK (1) | DK3271477T3 (en) |
WO (1) | WO2016150771A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109312333A (en) * | 2016-04-07 | 2019-02-05 | 诺维信公司 | The method for selecting that there is the enzyme of proteinase activity |
US11597963B2 (en) * | 2017-11-09 | 2023-03-07 | Biomillenia Sas | Microbial selection system |
GB201903237D0 (en) | 2019-03-08 | 2019-04-24 | Autolus Ltd | Method |
GB202207298D0 (en) * | 2022-05-18 | 2022-06-29 | Cambridge Entpr Ltd | Improved plastic degrading enzymes |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003044187A2 (en) * | 2001-11-16 | 2003-05-30 | Medical Research Council | Emulsion compositions |
US20060078888A1 (en) * | 2004-10-08 | 2006-04-13 | Medical Research Council Harvard University | In vitro evolution in microfluidic systems |
WO2010009365A1 (en) * | 2008-07-18 | 2010-01-21 | Raindance Technologies, Inc. | Droplet libraries |
CN102203277A (en) * | 2008-08-21 | 2011-09-28 | 诺维信公司 | Microfluidic device screening method |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2704860B1 (en) | 1993-05-05 | 1995-07-13 | Pasteur Institut | NUCLEOTIDE SEQUENCES OF THE LOCUS CRYIIIA FOR THE CONTROL OF THE EXPRESSION OF DNA SEQUENCES IN A CELL HOST. |
BR9507817A (en) | 1994-06-03 | 1997-09-16 | Novo Nordisk Biotech Inc | Construction of recombinant vector enzyme recombinant host cell laccase ascomycete or deuteromycete processes to obtain a laccase enzyme to improve the yield of recombinant enzyme to polymerize a lignin or lignosulfate substrate in solution to depolymerize the kraft paste to oxidize dyes or dye precursors to dye hair and to polymerize or oxidize a phenolic compound or aniline dye composition and container containing the same |
DE69838521T2 (en) | 1997-07-07 | 2008-05-21 | Medical Research Council | Method for increasing the concentration of nucleic acid molecules |
US5955310A (en) | 1998-02-26 | 1999-09-21 | Novo Nordisk Biotech, Inc. | Methods for producing a polypeptide in a bacillus cell |
DE10000463A1 (en) | 2000-01-07 | 2001-07-26 | Zeuna Staerker Kg | Flow switching element; has Coanda tulip, at least two outlets and displacement body with even flow surface joined to casing, with separating edge defining area between casing and flow surface |
JP2008546542A (en) | 2005-05-18 | 2008-12-25 | プレジデント・アンド・フエローズ・オブ・ハーバード・カレツジ | Production of conduction paths, microcircuits and microstructures in microfluidic networks |
EP2263787A3 (en) | 2006-01-27 | 2012-02-22 | President and Fellows of Harvard College | Fluidic droplet coalescence |
WO2007133710A2 (en) * | 2006-05-11 | 2007-11-22 | Raindance Technologies, Inc. | Microfluidic devices and methods of use thereof |
EP4019977A1 (en) | 2009-06-26 | 2022-06-29 | President and Fellows of Harvard College | Fluid injection |
WO2012019765A1 (en) | 2010-08-10 | 2012-02-16 | European Molecular Biology Laboratory (Embl) | Methods and systems for tracking samples and sample combinations |
GB201108259D0 (en) * | 2011-05-17 | 2011-06-29 | Cambridge Entpr Ltd | Gel beads in microfluidic droplets |
-
2016
- 2016-03-15 WO PCT/EP2016/055577 patent/WO2016150771A1/en active Application Filing
- 2016-03-15 US US15/560,017 patent/US10883102B2/en active Active
- 2016-03-15 DK DK16713319.8T patent/DK3271477T3/en active
- 2016-03-15 CN CN201680016459.8A patent/CN107406889B/en active Active
- 2016-03-15 EP EP16713319.8A patent/EP3271477B1/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003044187A2 (en) * | 2001-11-16 | 2003-05-30 | Medical Research Council | Emulsion compositions |
US20060078888A1 (en) * | 2004-10-08 | 2006-04-13 | Medical Research Council Harvard University | In vitro evolution in microfluidic systems |
WO2010009365A1 (en) * | 2008-07-18 | 2010-01-21 | Raindance Technologies, Inc. | Droplet libraries |
CN102203277A (en) * | 2008-08-21 | 2011-09-28 | 诺维信公司 | Microfluidic device screening method |
Non-Patent Citations (2)
Title |
---|
JINGDONG CHEN等: "Progress ofMicrofluidics for Biology andMedicine", 《NANO-MICRO LETTERS》 * |
李亮等: "基于数字PCR 的单分子DNA定量技术研究进展", 《生物化学与生物物理进展》 * |
Also Published As
Publication number | Publication date |
---|---|
EP3271477A1 (en) | 2018-01-24 |
WO2016150771A1 (en) | 2016-09-29 |
CN107406889B (en) | 2021-11-02 |
US10883102B2 (en) | 2021-01-05 |
EP3271477B1 (en) | 2020-06-24 |
DK3271477T3 (en) | 2020-09-14 |
US20180094255A1 (en) | 2018-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Holstein et al. | Cell-free directed evolution of a protease in microdroplets at ultrahigh throughput | |
Hardiman et al. | Directed evolution of a thermophilic β-glucosidase for cellulosic bioethanol production | |
JP4629783B2 (en) | Production of polypeptides in Bacillus cells | |
CN107406889A (en) | By injecting the selection based on drop carried out | |
JP5629584B2 (en) | Accelerated protein production in Bacillus | |
CN101070537A (en) | A method for in vivo production of a mutant library in cells | |
EP2431470B1 (en) | Dnase expression in recombinant host cells | |
CN101611145A (en) | Be used for modified messenger RNA stabilizing sequences at the bacterial cell expressing gene | |
CN107922934A (en) | Protease with modified pre-peptide region | |
Takemasa et al. | Thermococcus kodakarensis as a host for gene expression and protein secretion | |
CN109804072A (en) | The genome conformity that FLP is mediated in bacillus licheniformis | |
JP2016523077A (en) | Expression of naturally secreted polypeptide without signal peptide | |
Zhang et al. | Enhancing extracellular pullulanase production in Bacillus subtilis through dltB disruption and signal peptide optimization | |
CN107278230B (en) | Enhanced protein expression | |
Trung et al. | An auto-inducible phosphate-controlled expression system of Bacillus licheniformis | |
Meister et al. | Directed evolution of the 3C protease from coxsackievirus using a novel fluorescence-assisted intracellular method | |
Lee et al. | Sensitive and rapid phenotyping of microbes with soluble methane monooxygenase using a droplet-based assay | |
CN103154263A (en) | Induced sporulation screening method | |
CN106434733B (en) | A kind of expression vector and its application suitable for Corynebacterium glutamicum | |
JP2016521579A (en) | Production of a polypeptide that does not contain a secretion signal in the genus Bacillus | |
KR102500121B1 (en) | Enhanced protein expression | |
US20120329090A1 (en) | Methods for Producing Heterologous Polypeptides in Thiol-Disulfide Oxidoreductase-Deficient Bacterial Mutant Cells | |
Chen et al. | Structure and expression of an amylopullulanase gene from Bacillus stearothermophilus TS‐23 | |
Rabbani et al. | Cloning and Expression of Randomly Mutated Bacillus subtilis α‐Amylase Genes in HB101 | |
Lenz et al. | Analysis of protein secretion in Bacillus subtilis by combining a secretion stress biosensor strain with an in vivo split GFP assay |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |